ABSTRACT INTRODUCTION

51
Periconceptional folic acid (FA) supplementation has a proven effect in preventing the 52 first occurrence (1) and recurrence (2) of neural tube defects (NTD). As a result, women 53 planning a pregnancy are recommended to take 400 μg/d FA from preconception until the end 54 of the first trimester (3) . Apart from preventing NTD in early pregnancy, emerging evidence 55 shows that maternal folate status may have other roles in offspring health, particularly in 56 relation to cognitive development in childhood (4, 5) . Several observational studies have 57 identified a potential role of maternal folate status during pregnancy on the cognitive 58 performance of offspring (6, 7, 8) . We previously investigated the children of mothers who 59 had participated in a randomized trial in pregnancy of Folic Acid Supplementation in the
60
Second and Third Trimesters (FASSTT) (9) and, in a preliminary publication, found 61 beneficial effects of FA on cognition in children at age 3 and 6 years (10) . Although, the 62 precise biological mechanism explaining the effect of FA during pregnancy on 63 neurodevelopment of the child is unknown, it must involve the essential role of folate in one-64 carbon metabolism, whereby one-carbon units are transferred and utilized in critical pathways 65 involving amino acid metabolism, biosynthesis of purines and pyrimidines and the 66 methylation of biological substrates including DNA. 67 Epigenetics refers to heritable changes in gene expression, which occur without 68 altering the underlying DNA sequence, often via histone modification, RNA interference or 69 DNA methylation (11) . DNA methylation is the most widely studied epigenetic mechanism retrotransposon LINE-1, the imprinted genes IGF2 and PEG3 and the metastable epiallele 78 RBM46 (13, 14) . As shown by ourselves (15) and others (16) important neurotrophic factor frequently associated with epigenetic modulation (20) .
92
Therefore, the aim of this study was to investigate the effect of FA supplementation 
METHODS
97
Participants and Study Design
98
Samples for the current investigation were made available from a previous double- GW) was highly correlated with cord RBC folate (r = 0.619; P = <0.001; data not shown). CpG 3 where FA supplementation resulted in significantly higher DNA methylation (Table   210 3).
211
Multiple linear regression analysis was conducted on the whole cohort (placebo and
212
FA treated groups combined) in order to identify the maternal and neonatal determinants of
213
DNA methylation in cord blood ( can cause transcriptional alterations including at imprinted genes (15, 19) . Additionally, the 283 small changes that we observed may lead to an altered balance at imprinted loci globally (34) .
284
Like the current study, previous studies have also reported sex-specific differences in DNA they are considered estrogen-responsive genes (37, 38) , but the mechanisms underlying these 296 sex-specific effects shown here and elsewhere remain to be elucidated.
297
Apart from maternal FA treatment, vitamin B12 status and caesarean section delivery 
311
The main strength of this study is that it is a randomized trial and therefore has the investigated (12) (13) (14) (15) (16) (24) (25) (26) (27) are known to be similar across different tissues.
323
In conclusion, the current study presents the first evidence from an RCT that 2 Regression for cord DNA methylation was performed for each gene with adjustment for significant covariates, as appropriate. All genes were investigated; those showing significant relationships (for maternal or neonatal characteristic) are shown. 3 36 th GW refers to post-intervention. Abbreviations: GW, gestational week; RBC, red blood cell. 
